This early-stage study tests a new medicine called IDB-011 in 40 healthy adults to see if it is safe and how the body processes it. The medicine is designed to prevent Rift Valley Fever, a serious viral disease spread by mosquitoes. Participants receive either the medicine or a p…
Phase: PHASE1 • Sponsor: IDBiologics, Inc. • Aim: Prevention
Last updated May 04, 2026 16:20 UTC